Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$1.3 - $3.58 $6,939 - $19,110
5,338 Added 22.18%
29,400 $70,000
Q4 2023

Feb 09, 2024

BUY
$1.0 - $1.53 $24,062 - $36,814
24,062 New
24,062 $36,000
Q2 2022

Aug 05, 2022

BUY
$1.31 - $2.69 $13 - $26
10 Added 0.03%
29,400 $55,000
Q4 2021

Feb 08, 2022

BUY
$3.81 - $6.16 $670 - $1,084
176 Added 0.6%
29,390 $116,000
Q2 2021

Aug 10, 2021

BUY
$4.12 - $5.87 $1,573 - $2,242
382 Added 1.32%
29,214 $134,000
Q1 2020

May 05, 2020

SELL
$1.8 - $4.28 $396 - $941
-220 Reduced 0.76%
28,832 $56,000
Q2 2018

Aug 06, 2018

BUY
$7.8 - $13.69 $4,836 - $8,487
620 Added 2.18%
29,052 $349,000
Q3 2017

Oct 31, 2017

BUY
$12.17 - $16.3 $346,017 - $463,441
28,432
28,432 $349,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.